By contrast, high serum levels of AIFM2 or ACSL4 and absolute values of serum GPX4, AIFM2, or ACSL4 levels were not potential predictors of COPD-related hospitalization. This evidence concerns the gene ACSL4 and chronic obstructive pulmonary disease.